Earnings Feed
Start Free
Guardant Health, Inc.·4

Mar 17, 9:57 PM ET

Eltoukhy Helmy 4

Research Summary

AI-generated summary

Updated

Guardant Health (GH) CEO Helmy Eltoukhy Exercises Awards, Withholds Shares

What Happened

  • Helmy Eltoukhy, CEO of Guardant Health (GH), converted/ exercised derivative awards on Jan 1, 2026 (38,283 shares) and Mar 13, 2026 (26,961 shares) for a total of 65,244 shares acquired on conversion. To satisfy tax withholding obligations, the company retained (disposed) 19,402 shares on Jan 1 at $102.14 each ($1,981,720) and 13,664 shares on Mar 13 at $85.49 each ($1,168,135), totaling 33,066 shares withheld and about $3.15M in value. On Mar 17, 2026 he was granted RSU awards totaling 112,677 shares (11,268 + 101,409) per the filing.

Key Details

  • Transaction dates and prices:
    • 2026-01-01: Converted/exercised 38,283 derivative shares (no cash exercise price reported); 19,402 shares withheld for taxes at $102.14 = $1,981,720.
    • 2026-03-13: Converted/exercised 26,961 derivative shares; 13,664 shares withheld for taxes at $85.49 = $1,168,135.
    • 2026-03-17: Grants of RSUs totaling 112,677 shares (two awards).
  • Total withheld to cover taxes: 33,066 shares ≈ $3,149,855.
  • Footnotes of note:
    • F1: Some lines reflect a change in form of ownership (transfer to the Helmy A. Eltoukhy Revocable Trust).
    • F2: Shares retained by the company were to satisfy tax withholding and were not in excess of the tax liability.
    • F3/F5/F6: Describe vesting schedules for prior and new RSU awards (some vested Jan 1, 2026; others vest quarterly or over three years).
  • Shares owned after the transactions: not specified in the provided filing details.
  • Filing date: Form 4 was filed 2026-03-17 covering transactions from Jan 1 and Mar 13 as well as the Mar 17 grants. Note that Form 4s are generally due within two business days of the transaction; reporting multiple earlier transactions on 3/17 may be later than the typical deadline.

Context

  • The conversions/exercises appear tied to RSU/derivative vesting and were followed by share-withholding to satisfy tax obligations (a routine administrative action, not an open-market sale by the insider). The withheld shares are reported as disposals for tax purposes (code F). The new RSU grants are subject to vesting schedules (see footnotes) and are not immediate purchases or sales.